Condition
Posttraumatic Deformity
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Terminated2
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03664791Unknown
Vanguard Rocc Post Market Surveillance
NCT02175576Not ApplicableTerminated
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
NCT02088372Terminated
Prospective Multi-Center Study on Vanguard With E1 Bearing
NCT03932734Unknown
Patient Satisfaction After Patient-specific Jawline Augmentation
NCT01906177Completed
A Prospective Munti-center Study on VANGUARD™ PS Total Knee Replacement System
Showing all 5 trials